Low-dose aspirin therapy is found to be good for preventing myocardial infarction or stroke among patients with diabetes at high risk for cardiovascular disease.
A joint statement released by the American Diabetes Association, American College of Cardiology and American Heart Association disclosed this.
The statement was published online in the Journal of the American College of Cardiology, Diabetes Care and Circulation: Journal of the American Heart Association.
It said that the overall data suggested that aspirin moderately reduces the risk. However, it said that more research was needed to better define the specific effects of aspirin on diabetes.
The statement said the use of aspirin therapy depended on the use of other treatments like cholesterol-lowering medications, smoking cessation and blood pressure control.
In 2007, the ADA and AHA had issued a joint recommendation for 75 mg to 162 mg aspirin per day for men and women aged 40 years or older with a major risk factor for CVD.
Low-dose aspirin is not recommended for CV prevention for men younger than 50 years and women younger than 60 years with diabetes.
